340B药品折扣计划在近期癌症护理趋势中的作用。

Role of the 340B Drug Discount Program in Recent Cancer Care Trends.

作者信息

Kantarjian Hagop M, Chapman Robert

机构信息

The University of Texas MD Anderson Cancer Center, Houston, TX; and Josephine Ford Cancer Institute, Brownstown Charter Township, MI

The University of Texas MD Anderson Cancer Center, Houston, TX; and Josephine Ford Cancer Institute, Brownstown Charter Township, MI.

出版信息

J Oncol Pract. 2015 Jul;11(4):303-7. doi: 10.1200/JOP.2014.002139. Epub 2015 Jun 2.

DOI:10.1200/JOP.2014.002139

PMID:26036268

Abstract

The 340B program, a drug discount program created by the US Congress, allows safety-net providers to access discounted drug pricing that helps low-income and vulnerable patients. This program has recently been the subject of significant discussions as to its potential implications. Herein we review the role of the 340B drug discount program and its relevance to recent trends in cancer care and to the access of safety-net providers and vulnerable patients to much-needed drug support.

摘要

340B计划是美国国会设立的一项药品折扣计划，它允许安全网医疗机构获取药品折扣价格，以帮助低收入和弱势患者。该计划最近成为了关于其潜在影响的大量讨论的主题。在此，我们回顾340B药品折扣计划的作用，及其与癌症治疗近期趋势、安全网医疗机构和弱势患者获得急需药品支持的相关性。